Catalyst Wire Dossier Catalyst Wire Dossier

MK-0663/Etoricoxib

etoricoxib · Organon and Co
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0663/Etoricoxib, covering 2020-04-07 to 2020-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098) [Phase 3]

See pricing